o | Preliminary Proxy Statement |
o | Cofidential, for Use of the Commission Only
(as
permitted by Rule
14a-6(5)(2))
|
x | Definitive Proxy Statement |
o | Definitive Additional Materials |
o | Soliciting Material Pursuant to §240.14a-12 |
x | No fee required. | |
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
(1) | Title of each class of securities to which transaction applies: | |
(2) | Aggregate number of securities to which transaction applies: | |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): | |
(4) | Proposed maximum aggregate value of transaction: | |
(5) | Total fee paid: | |
o | Fee paid previously with preliminary materials. | |
o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration number, or the Form or Schedule and the date of its filing. | |
(1) | Amount Previously Paid: | |
(2) | Form, Schedule or Registration Statement No.: | |
(3) | Filing Party: | |
(4) | Date Filed: |
1. |
Election
of 10 directors to the Board of Directors to serve until the
2008 annual
meeting of stockholders;
|
2. |
Ratification
of the appointment of Deloitte & Touche LLP as the Company's
independent registered public accounting firm for
2007;
|
3. |
Approval
of an amendment to our Long-Term Incentive Plan, which includes
authorization for 5 million additional
shares;
|
4. | Approval of the 2007 Executive Incentive Plan; and |
5. | To act upon such other matters, if any, as may properly come before the meeting. |
ABOUT THE ANNUAL MEETING |
1
|
|
PROPOSAL
NO. 1 ELECTION OF DIRECTORS
|
6
|
|
|
Nominees for Election to Our Board |
6
|
CORPORATE
GOVERNANCE
|
8
|
|
MEETINGS AND COMMITTEES OF THE BOARD |
11
|
|
COMPENSATION COMMITTEE REPORT |
13
|
|
COMPENSATION DISCUSSION AND ANALYSIS |
13
|
|
ADDITIONAL INFORMATION REGARDING EXECUTIVE COMPENSATION |
17
|
|
|
Summary
Compensation Table
|
17
|
|
2006
Grants of Plan-Based Awards Table
|
18
|
Outstanding Equity Awards at 2006 Fiscal Year-End Table |
19
|
|
2006 Option Exercises and Stock Vested Table |
19
|
|
2006 Non-Qualified Deferred Compensation Table |
20
|
|
Potential Payments Upon Termination or Change in Control |
21
|
|
NON-MANAGEMENT
DIRECTOR COMPENSATION
|
22
|
|
INFORMATION
CONCERNING OUR EXECUTIVE OFFICERS
|
24
|
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
25
|
|
STOCK
OWNERSHIP GUIDELINES
|
27
|
|
SECTION
16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
|
27
|
|
PROPOSAL NO. 2 RATIFICATION OF APPOINTMENT BY THE AUDIT COMMITTEE OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2007 |
28
|
|
|
2006
and 2005 Audit Fees
|
28
|
AUDIT
COMMITTEE REPORT
|
29
|
|
PROPOSAL
NO. 3 APPROVAL OF AN AMENDMENT TO 2004 LONG-TERM INCENTIVE
PLAN
|
31
|
|
PROPOSAL
NO. 4 APPROVAL OF 2007 EXECUTIVE INCENTIVE PLAN
|
38
|
|
OTHER
MATTERS
|
39
|
|
1. |
The
election of the following 10 directors to the Board to serve until
the
2008 annual meeting of stockholders:
|
· John
C. Brouillard
|
· William
S. Oglesby
|
· Lawrence
P. Castellani
|
· Gilbert
T. Ray
|
· Michael
N. Coppola
|
· Carlos
A. Saladrigas
|
· Darren
R. Jackson
|
· William
L. Salter
|
· Nicholas
J. LaHowchic
|
· Francesca
M. Spinelli
|
2. |
Ratification
of the appointment of Deloitte & Touche LLP (“Deloitte”) as the
Company’s independent registered public accounting firm for
2007.
|
3. |
Approval
of an amendment to our Long-Term Incentive Plan, which includes
authorization for 5 million additional
shares.
|
4. |
Approval
of the 2007 Executive Incentive
Plan.
|
1. |
FOR
each of the director nominees
|
2 |
FOR
ratification of the appointment of Deloitte as independent registered
public accounting firm for 2007
|
3. |
FOR
approval of the amendment to our Long-Term Incentive
Plan
|
4. |
FOR
approval of the 2007 Executive Incentive
Plan
|
· |
By
Internet at www.proxyvote.com;
|
· |
By
toll-free telephone at 1-800-690-6903;
|
· |
By
completing and mailing your proxy card; and
|
· |
By
written ballot at the Annual
Meeting.
|
· |
Entering
a new vote by Internet or telephone;
|
· |
Returning
a later-dated proxy card;
|
· |
Sending
written notice of revocation to Eric M. Margolin, Senior Vice
President,
General Counsel and Secretary, at the Company’s address of record, which
is 5008 Airport Road, Roanoke, VA 24012; or
|
· |
Completing
a written ballot at the Annual
Meeting.
|
Name
|
Age
|
Position
|
|||
John
C. Brouillard(1)(2)
|
58
|
Lead
Director
|
|||
Lawrence
P. Castellani(3)
|
61
|
Director
|
|||
Michael
N. Coppola
|
58
|
Chairman
of the Board, President and Chief Executive Officer
|
|||
Darren
R. Jackson(1)(3)
|
42
|
Director
|
|||
Nicholas
J. LaHowchic(3)
|
59
|
Director
|
|||
William
S. Oglesby(3)(4)
|
47
|
Director
|
|||
Gilbert
T. Ray(2)(4)
|
62
|
Director
|
|||
Carlos
A. Saladrigas(1)
|
58
|
Director
|
|||
William
L. Salter(2)(4)
|
63
|
Director
|
|||
Francesca
M. Spinelli(2)
|
53
|
Director
|
(1) | Member of Audit Committee |
(2) |
Member
of Compensation Committee
|
(3) |
Member
of Finance Committee
|
(4) |
Member
of Nominating and Corporate Governance
Committee
|
· |
the
structure of our Board including, among other things, the size, mix
of
independent and non-independent members, membership criteria, term
of
service, compensation and assessment of performance of our
Board;
|
· |
Board
procedural matters, including among other things, selection of the
chair
of the Board, Board meetings, Board communications, retention of
counsel
and advisors and our expectations regarding the performance of our
directors;
|
· |
committee
matters including, among other things, the types of committees, charters
of committees, independence of committee members, chair of committees,
service of committee members, committee agendas and committee minutes
and
reports;
|
· | chief executive officer evaluation, management development and succession planning; |
· | codes of conduct; and |
· |
other
matters, including charitable contributions, use of the corporate
airplane, auditor services, Board access to management and interaction
with third parties, directors and officers insurance and the
indemnification/limitation of liability of directors, our policy
prohibiting Company loans to the Company’s executive officers and
directors, and confidential stockholder
voting.
|
Name
of Committee and Members
|
Primary
Responsibilities
|
#
of Meetings
in
2006
|
Audit
Carlos
A. Saladrigas (Chair)
John
C. Brouillard
Darren
R. Jackson
|
· monitors
the integrity of our financial statements, reporting processes, internal
controls, risk management and legal and regulatory
compliance;
· selects,
determines the compensation of, evaluates and, when appropriate,
replaces
our independent registered public accounting firm; pre-approves all
audit
and permitted non-audit services;
· monitors
the qualifications, independence and performance of our independent
registered public accounting firm; and
· oversees
our internal audit function.
|
12
|
Compensation
Francesca
M. Spinelli (Chair)
John
C. Brouillard
Gilbert
T. Ray
William
L. Salter
|
· reviews
and approves our executive compensation philosophy;
· annually
reviews and approves corporate goals and objectives relevant to the
compensation of the CEO and evaluates the CEO’s performance in light of
these goals;
· determines
the compensation of our executive officers and approves compensation
for
key members of management; and
· oversees
our incentive and equity-based compensation plans.
|
6
|
Finance
William
S. Oglesby (Chair)
Lawrence
P. Castellani
Darren
R. Jackson
Nicholas
J. LaHowchic
|
· reviews
and makes recommendations to the Board regarding our financial policies,
including investment guidelines, deployment of capital and short-term
and
long-term financing;
· reviews
credit metrics, including debt ratios, levels and leverage
ratios;
· reviews
all aspects of financial planning, strategic planning, cash uses
and our
expansion program; and
· reviews
and recommends the annual budget to the Board.
|
8
|
Nominating
and Corporate Governance
Gilbert
T. Ray (Chair)
William
S. Oglesby
William
L. Salter
|
· assists
the Board in identifying, evaluating and recommending candidates
for
election to the Board;
· establishes
procedures and provides oversight for evaluating the Board and
management;
· develops,
recommends and reassesses our corporate governance guidelines;
and
· evaluates
the size, structure and composition of the Board and its
committees.
|
4
|
· |
compensation
for executive officers is linked to annual and long-term Company
performance goals that are structured to align the interests of
executive
officers with those of the Company’s stockholders;
|
· |
a
significant portion of total compensation is stock-based, thereby
further
aligning the interests of executive officers and Company stockholders;
and
|
· |
executive
compensation is comparable with compensation levels at major retail
competitors so the Company can attract, retain and motivate superior
management talent essential to the Company’s long-term
success.
|
AutoZone | Barnes & Noble | Bed Bath & Beyond | Borders Group |
Circuit City | CSK Auto | Dollar General | Dollar Tree |
Foot Locker | Genuine Parts | Longs Drug Stores | Michaels |
O’Reilly Automotive | Payless Shoesource | The Pep Boys | PetSmart |
RadioShack | Williams-Sonoma |
· |
base
salary, which is intended to compensate executives for their
primary
responsibilities and individual contributions;
|
· |
performance-based
incentives, which are intended to link annual compensation and
short-term
performance;
|
· |
long-term
equity incentives, which are intended to link long-term compensation
with
stockholder value over the long term; and
|
· |
retirement
savings and other
compensation
|
Name
and
Principal
Position
|
Year
|
Salary
($)
|
Option
Awards
(a)
($)
|
Non-Equity
Incentive
Plan
Compensation(b)
($)
|
Change
in Pension
Value
and Non-
Qualified
Deferred
Compensation
Earnings
(c)
($)
|
All
Other
Compensation
(d)
(e) (f) (g) (h)
($)
|
Total
($)
|
|||||||||||||||
Michael
N. Coppola
|
2006
|
|
$
772,502
|
|
$
2,383,314
|
|
$
54,990
|
|
$
6,675
|
|
$
23,059
|
|
$
3,240,540
|
|||||||||
Chairman,
President
|
||||||||||||||||||||||
and
Chief Executive Officer
|
||||||||||||||||||||||
Michael
O. Moore
|
2006
|
380,260
|
439,592
|
16,159
|
-
|
106,899
|
942,910
|
|||||||||||||||
EVP,
Chief Financial Officer
|
||||||||||||||||||||||
Jimmie
L. Wade
|
2006
|
481,510
|
1,223,406
|
20,548
|
3,188
|
17,496
|
1,746,148
|
|||||||||||||||
EVP,
Business Development
|
||||||||||||||||||||||
Paul
W. Klasing
|
2006
|
358,748
|
857,274
|
15,334
|
1,367
|
16,698
|
1,249,421
|
|||||||||||||||
EVP,
Stores
|
||||||||||||||||||||||
David
B. Mueller
|
2006
|
341,234
|
727,592
|
14,699
|
-
|
11,458
|
1,094,983
|
|||||||||||||||
EVP,
Merchandising & Marketing
|
(a) | Represents the fair value of employee stock options which vested during 2006, consistent with the provisions of Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment.” The assumptions of the Black-Scholes valuation method are discussed in Part 4, Item 15 of the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2007. |
(b) | Amounts in this column were paid to the named executives in March 2007 according to the annual incentive plan in place for our 2006 fiscal year. |
(c) | Represents unrealized gains or losses on market-based investments selected by executives for their deferred compensation balances. |
(d) | Company matching contributions according to the terms of the Company’s 401(k) plan are included in this column. |
(e) | Includes life insurance premiums paid by the Company for coverage equal to one times the executive’s annual salary according to our normal life insurance benefit, and an equivalent amount required to cover a benefit stated in the terms of each executive’s employment contract. |
(f) | Company expenses related to executive allowance reimbursements for 2006 were as follows: Mr. Coppola - $14,000 for personal automobile use; Mr. Moore - $9,000 for personal automobile use and supplemental insurance; Mr. Wade - $9,000 for personal automobile use; Mr. Klasing - $9,000 for personal automobile use, supplemental insurance and fitness club use; and Mr. Mueller- $9,000 for personal automobile use, supplemental insurance and financial planning. Information about these taxable perquisites is provided under the heading “Other Compensation” of this proxy statement. |
(g) | For Mr. Moore, this column also includes reimbursement of $57,481 for moving expenses and a tax reimbursement in the amount of $39,594 provided in accordance with the Company’s relocation program. |
(h) | This column also includes the value of any personal use of the Company aircraft calculated as the incremental cost to the Company and tax reimbursements related to personal use of the Company aircraft. Individual expenses related to plane use and any related tax reimbursements provided in accordance with the Company’s plane use policy, respectively, for 2006 were as follows: Mr. Coppola - $1,191 and $528; Mr. Wade - $1,191 and $528; Mr. Klasing - $1,191 and $264; and Mr. Mueller - $1,191 and $528. The incremental cost to the Company for personal use of Company aircraft is calculated based on the primary variable operating costs to the Company, including fuel, maintenance and other miscellaneous variable costs. Tax reimbursement amounts are based on the taxable value of the personal use calculated in accordance with IRS regulations. |
Estimated
Future Payouts Under Non-Equity Incentive Plan
Awards
|
|
|
|
|||||||||||||||||||
Name
|
Grant
Date
|
Threshold ($)
|
Target
($)
|
Maximum
($)
|
All
Other Option Awards: Number of Securities Underlying Options
(#)
|
Exercise
Price
of
Option
Awards
($)
|
Grant
Date Fair
Value
of Stock
and
Option
Awards
($)
|
|||||||||||||||
Mr.
Coppola
|
2/21/2006
|
|
$
136,500
|
|
$
780,000
|
|
$
1,560,000
|
210,000
|
|
$
40.45
|
|
$
2,244,900
|
||||||||||
Mr.
Moore
|
2/21/2006
|
40,111
|
229,207
|
458,414
|
90,000
|
|
40.45
|
962,100
|
||||||||||||||
Mr.
Wade
|
2/21/2006
|
51,005
|
291,458
|
582,916
|
105,000
|
|
40.45
|
1,122,450
|
||||||||||||||
Mr.
Klasing
|
2/21/2006
|
38,063
|
217,501
|
435,002
|
90,000
|
|
40.45
|
962,100
|
|
|||||||||||||
Mr.
Mueller
|
2/21/2006
|
36,486
|
208,490
|
416,980
|
90,000
|
|
40.45
|
962,100
|
Option
Awards
|
||||||||||||||||
Name
|
Number
of
Securities
Underlying Unexercised
Options
(#) Exercisable
|
Number
of
Securities
Underlying Unexercised
Options
(#) Unexercisable
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Outstanding
Vesting Dates
|
|||||||||||
Mr.
Coppola
|
30,000
|
-
|
$
|
7.00
|
4/5/2008
|
Vested
|
||||||||||
36,000
|
-
|
14.00
|
3/12/2009
|
Vested
|
||||||||||||
42,000
|
-
|
13.46
|
2/18/2010
|
Vested
|
||||||||||||
45,000
|
-
|
24.34
|
8/18/2010
|
Vested
|
||||||||||||
70,000
|
35,000
|
26.21
|
2/23/2011
|
Balance
vested on February 23, 2007
|
||||||||||||
100,000
|
50,000
|
23.88
|
9/14/2011
|
Balance
vests on September 14, 2007
|
||||||||||||
100,000
|
200,000
|
33.37
|
2/22/2012
|
Equally
vests on February 22, 2007 and 2008
|
||||||||||||
-
|
210,000
|
40.45
|
2/21/2013
|
Equallly
vests on February 21, 2007, 2008 and 2009
|
||||||||||||
|
||||||||||||||||
Mr.
Moore
|
15,000
|
30,000
|
42.10
|
12/19/2012
|
Equally
vests on December 19, 2007 and 2008
|
|||||||||||
-
|
90,000
|
40.45
|
2/21/2013
|
Equallly
vests on February 21, 2007, 2008 and 2009
|
||||||||||||
Mr.
Wade
|
109,999
|
-
|
14.00
|
3/12/2009
|
Vested
|
|||||||||||
40,000
|
-
|
13.46
|
2/18/2010
|
Vested
|
||||||||||||
45,000
|
-
|
24.34
|
8/18/2010
|
Vested
|
||||||||||||
90,000
|
45,000
|
26.21
|
2/23/2011
|
Balance
vested on February 23, 2007
|
||||||||||||
45,000
|
90,000
|
33.37
|
2/22/2012
|
Equally
vests on February 22, 2007 and 2008
|
||||||||||||
-
|
105,000
|
40.45
|
2/21/2013
|
Equallly
vests on February 21, 2007, 2008 and 2009
|
||||||||||||
Mr.
Klasing
|
75,000
|
-
|
7.00
|
4/5/2008
|
Vested
|
|||||||||||
90,000
|
-
|
14.00
|
3/12/2009
|
Vested
|
||||||||||||
90,000
|
-
|
13.46
|
2/18/2010
|
Vested
|
||||||||||||
15,000
|
-
|
24.34
|
8/18/2010
|
Vested
|
||||||||||||
60,000
|
30,000
|
26.21
|
2/23/2011
|
Balance
vested on February 23, 2007
|
||||||||||||
30,000
|
60,000
|
33.37
|
2/22/2012
|
Equally
vests on February 22, 2007 and 2008
|
||||||||||||
-
|
90,000
|
40.45
|
2/21/2013
|
Equally
vests on February 21, 2007, 2008 and 2009
|
||||||||||||
|
||||||||||||||||
Mr.
Mueller
|
20,000
|
10,000
|
26.21
|
2/23/2011
|
Balance
vested on February 23, 2007
|
|||||||||||
20,000
|
10,000
|
27.51
|
11/10/2011
|
Balance
vests on November 10, 2007
|
||||||||||||
30,000
|
60,000
|
33.37
|
2/22/2012
|
Equally
vests on February 22, 2007 and 2008
|
||||||||||||
-
|
90,000
|
40.45
|
2/21/2013
|
Equally
vests on February 21, 2007, 2008 and 2009
|
Name
|
Executive
Contributions
in
Last
FY (a) (b)
($)
|
Registrant
Contributions
in
Last
FY (a)
($)
|
Aggregate
Earnings
in
Last FY (a) (b)
($)
|
Aggregate
Withdrawals/
Distributions
($)
|
Aggregate
Balance
at
Last FYE
($)
|
Mr.
Coppola
|
$155,056
|
-
|
$6,675
|
-
|
$231,397
|
Mr.
Moore
|
-
|
-
|
-
|
-
|
-
|
Mr.
Wade
|
60,900
|
-
|
3,188
|
-
|
287,365
|
Mr.
Klasing
|
35,736
|
-
|
1,367
|
-
|
123,051
|
Mr.
Mueller
|
-
|
-
|
-
|
-
|
-
|
(a)
|
Additional
information is provided under “Retirement Savings” in the Compensation
Discussion and Analysis section of this proxy
statement.
|
(b)
|
Any amounts reported in columns for “Executive Contributions” or “Aggregate Earnings” are also reported as salary in the Summary Compensation Table of this proxy statement. |
Executive and Benefits
|
Voluntary
Termination
or
Due
Cause
(a)
|
Retirement
|
Disability
|
Death
|
By
Company Other
than
Retirement,
Disability,
Death,
or
Due Cause or by
Employee
for Good
Reason(a)
|
Change
in
Control
|
|||||||||||||
Mr.
Coppola
|
|||||||||||||||||||
Salary
Continuation
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
780,000
|
$
|
780,000
|
$
|
-
|
|||||||
Annual
Incentive Plan (b)
|
-
|
54,990
|
54,990
|
54,990
|
54,990
|
-
|
|||||||||||||
Stock
Options (c) (d) (e)
|
5,107,470
|
6,456,225
|
6,456,225
|
6,456,225
|
5,107,470
|
6,456,225
|
|||||||||||||
Healthcare
(f)
|
-
|
-
|
8,098
|
-
|
8,098
|
-
|
|||||||||||||
Life
Insurance
|
-
|
-
|
-
|
780,000
|
-
|
-
|
|||||||||||||
Disability
(g)
|
-
|
-
|
702,000
|
-
|
-
|
-
|
|||||||||||||
Deferred
Compensation (h)
|
231,397
|
231,397
|
231,397
|
231,397
|
231,397
|
231,397
|
|||||||||||||
Mr.
Moore
|
|||||||||||||||||||
Salary
Continuation
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
382,013
|
$
|
382,013
|
$
|
-
|
|||||||
Annual
Incentive Plan (b)
|
-
|
16,159
|
16,159
|
16,159
|
16,159
|
-
|
|||||||||||||
Stock
Options (c) (d) (e)
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||
Healthcare
(f)
|
-
|
-
|
7,282
|
-
|
7,282
|
-
|
|||||||||||||
Life
Insurance
|
-
|
-
|
-
|
382,013
|
-
|
-
|
|||||||||||||
Disability
(g)
|
-
|
-
|
343,812
|
-
|
-
|
-
|
|||||||||||||
Deferred
Compensation (h)
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||
Mr.
Wade
|
|||||||||||||||||||
Salary
Continuation
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
485,763
|
$
|
485,763
|
$
|
-
|
|||||||
Annual
Incentive Plan (b)
|
-
|
20,548
|
20,548
|
20,548
|
20,548
|
-
|
|||||||||||||
Stock
Options (c) (d) (e)
|
4,700,663
|
5,318,378
|
5,318,378
|
5,318,378
|
4,700,663
|
5,318,378
|
|||||||||||||
Healthcare
(f)
|
-
|
-
|
8,098
|
-
|
8,098
|
-
|
|||||||||||||
Life
Insurance
|
-
|
-
|
-
|
485,763
|
-
|
-
|
|||||||||||||
Disability
(g)
|
-
|
-
|
437,187
|
-
|
-
|
-
|
|||||||||||||
Deferred
Compensation (h)
|
287,365
|
287,365
|
287,365
|
287,365
|
287,365
|
287,365
|
|||||||||||||
Mr.
Klasing
|
|||||||||||||||||||
Salary
Continuation
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
362,502
|
$
|
362,502
|
$
|
-
|
|||||||
Annual
Incentive Plan (b)
|
-
|
15,334
|
15,334
|
15,334
|
15,334
|
-
|
|||||||||||||
Stock
Options (c) (d) (e)
|
6,866,490
|
7,278,300
|
7,278,300
|
7,278,300
|
6,866,490
|
7,278,300
|
|||||||||||||
Healthcare
(f)
|
-
|
-
|
8,098
|
-
|
8,098
|
-
|
|||||||||||||
Life
Insurance
|
-
|
-
|
-
|
362,502
|
-
|
-
|
|||||||||||||
Disability
(g)
|
-
|
-
|
326,252
|
-
|
-
|
-
|
|||||||||||||
Deferred
Compensation (h)
|
123,051
|
123,051
|
123,051
|
123,051
|
123,051
|
123,051
|
|||||||||||||
Mr.
Mueller
|
|||||||||||||||||||
Salary
Continuation
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
347,484
|
$
|
347,484
|
$
|
-
|
|||||||
Annual
Incentive Plan (b)
|
-
|
14,669
|
14,669
|
14,669
|
14,669
|
-
|
|||||||||||||
Stock
Options (c) (d) (e)
|
413,610
|
718,830
|
718,830
|
718,830
|
413,610
|
718,830
|
|||||||||||||
Healthcare
(f)
|
-
|
-
|
8,000
|
-
|
8,000
|
-
|
|||||||||||||
Life
Insurance
|
-
|
-
|
-
|
347,484
|
-
|
-
|
|||||||||||||
Disability
(g)
|
-
|
-
|
312,736
|
-
|
-
|
-
|
|||||||||||||
Deferred
Compensation (h)
|
-
|
-
|
-
|
-
|
-
|
-
|
(a) | Termination for due cause makes an executive ineligible for any employment agreement benefits other than any rights he may have under the normal terms of other benefit plans. Unvested options expire 90 days after the date of termination. |
(b) | Executives are eligible only for annual incentive payments earned prior to their termination date. The delivery of any such payments would coincide with the regular payment date for other executives. Refer to the “Grants of Plan-Based Awards Table” |
for the range of potential payments. Actual amounts earned for 2006 are shown here. In the case of voluntary termination or termination for due cause, the executive would be ineligible to receive the payment because he would not have been actively employed on the date of distribution. | |
(c) | Amounts shown here are calculated as the differences between the exercise price of the outstanding stock options and the closing price of our stock at the end of our fiscal year ($35.56). Mr. Moore had no “in-the-money” stock options at the end of our fiscal year. |
(d) | An executive’s retirement, defined as age 55 plus 10 years of service, allows all unvested stock options to continue vesting into retirement. “Retirement” column amounts indicate the value of all outstanding options, based on footnote (c), assuming all executives qualify for retirement. |
(e) | The terms of executives’ stock option agreements provide that all stock options are 100% vested when a change in control occurs, unless an equivalent substitute equity award is provided by the acquiring company. |
(f) | Amounts provided here represent the Company’s cost of providing one year of healthcare coverage to the executive. |
(g) | Disability amounts shown consist of the amount the executives receive under the Company’s qualified plan plus an amount equal to 30% of their annual salary as specified in their employment agreements. |
(h) | Executives’ deferred compensation balances are always 100% vested and are not affected by any type of termination. |
Board
Participation Type
|
Retainer/Fee
|
|
Lead
Director
|
$
25,000
|
|
Audit
Committee Chair
|
$
15,000
|
|
Compensation
Committee Chair
|
$
10,000
|
|
Finance
Committee Chair
|
$
10,000
|
|
Nominating
and Corporate Governance Committee Chair
|
$
10,000
|
|
Attendance
at each Board Meeting
|
$
2,000
|
|
If
Attendance is Telephonic
|
$
1,000
|
|
Attendance
at each Committee Meeting
|
$
1,000
|
|
If
Attendance is Telephonic
|
$
750
|
Name
|
Fees
Earned or
Paid
in Cash
(a)
($)
|
Stock
Awards
(b)
($)
|
Option
Awards
($)
(c)
|
All
Other
Compensation
($)
(d)
|
Total
($)
|
|||||||||||
John
C. Brouillard
|
|
$
49,250
|
|
$
31,639
|
$
|
65,544
|
|
$
729
|
$
|
147,162
|
||||||
Lawrence
P. Castellani
|
40,250
|
31,639
|
1,185,244
|
149
|
1,257,282
|
|||||||||||
Darren
R. Jackson
|
50,000
|
31,639
|
62,193
|
513
|
144,345
|
|||||||||||
Nicholas
J. LaHowchic
|
35,250
|
31,639
|
19,712
|
257
|
86,858
|
|||||||||||
William
S. Oglesby
|
56,000
|
31,639
|
57,036
|
699
|
145,374
|
|||||||||||
Gilbert
T. Ray
|
54,500
|
31,639
|
77,958
|
596
|
164,693
|
|||||||||||
Carlos
A. Saladrigas
|
56,500
|
31,639
|
98,768
|
546
|
187,453
|
|||||||||||
William
L. Salter
|
69,500
|
31,639
|
94,904
|
629
|
196,672
|
|||||||||||
Francesca
M. Spinelli
|
50,500
|
31,639
|
93,299
|
645
|
176,083
|
(a) | Information includes paid or deferred board annual retainers, chair retainers and board and committee meeting fees paid to directors based on their respective meeting attendance during 2006. |
(b) | Deferred Stock Unit grant value is based on the number of units granted multiplied by the stock price ($38.35) on May 22, 2006, the grant date. |
(c) | Represents the fair value of employee stock options which vested during 2006, consistent with the provisions of Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment.” The assumptions of the Black-Scholes valuation method are discussed in Part 4, Item 15 of the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2007. The grant date fair value per option was $10.25 for the 2006 grant. |
(d) | Figures reported are the value of dividends earned on Deferred Stock Units and converted to additional deferred stock units. |
Name
|
Outstanding
Stock
Options
(#)
|
Outstanding
Deferred
Stock
Units
(#)
|
||
John
C. Brouillard
|
22,500
|
3,251
|
||
Lawrence
P. Castellani (a)
|
742,500
|
828
|
||
Darren
R. Jackson
|
21,250
|
2,348
|
||
Nicholas
J. LaHowchic
|
7,500
|
1,427
|
||
William
S. Oglesby
|
19,375
|
3,291
|
||
Gilbert
T. Ray
|
28,750
|
2,694
|
||
Carlos
A. Saladrigas
|
45,000
|
2,486
|
||
William
L. Salter
|
48,124
|
2,833
|
||
Francesca
M. Spinelli
|
48,750
|
2,901
|
(a) | Grants for Mr. Castellani reflect those awarded to him during his tenure as our past chief executive officer and chairman and other grants awarded to him under our director compensation arrangement, all of which continue to vest during his service as a board member. |
Name
|
Age
|
Position
|
|||
Michael
N. Coppola
|
58
|
Chairman,
President and Chief Executive Officer and Director
|
|||
Paul
W. Klasing
|
47
|
Executive
Vice President, Stores
|
|||
Michael
O. Moore
|
56
|
Executive
Vice President, Chief Financial Officer
|
|||
David
B. Mueller
|
48
|
Executive
Vice President, Merchandising and Marketing
|
|||
Elwyn
G. Murray III
|
40
|
Executive
Vice President, Administration
|
|||
Jimmie
L. Wade
|
52
|
Executive
Vice President, Business Development
|
|||
Eric
M. Margolin
|
53
|
Senior
Vice President, General Counsel and Secretary
|
|||
Keith
A. Oreson
|
50
|
Senior
Vice President, Human Resources
|
· |
each
person or entity known to us that beneficially owns more than 5%
of our
common stock;
|
· |
each
member of our Board;
|
· |
each
of our executive officers named in the “Summary Compensation Table”
included in the “Executive Compensation” section of this proxy statement;
and
|
· |
all
directors and executive officers as a
group.
|
Shares
Beneficially Owned
|
||||||||||
Name
of Beneficial Owner
|
Number
|
Percentage
|
||||||||
T.
Rowe Price Associates, Inc.(1)
100
E. Pratt Street
Baltimore,
Maryland 21202
|
5,620,985
|
5.3%
|
||||||||
Lawrence
P. Castellani(2)
|
706,958
|
*
|
||||||||
Michael
N. Coppola(3)
|
698,616
|
*
|
||||||||
John
C. Brouillard(4)
|
18,256
|
*
|
||||||||
Darren
R. Jackson(5)
|
14,019
|
*
|
||||||||
Nicholas
J. LaHowchic(6)
|
9,930
|
*
|
||||||||
William
S. Oglesby(7)
|
16,213
|
*
|
||||||||
Gilbert
T. Ray(8)
|
29,049
|
*
|
||||||||
Carlos
A. Saladrigas(9)
|
39,990
|
*
|
||||||||
William
L. Salter(10)
|
45,337
|
*
|
||||||||
Francesca
M. Spinelli(11)
|
45,656
|
*
|
||||||||
Paul
W. Klasing(3)(12)
|
509,259
|
*
|
||||||||
Michael
O. Moore(3)
|
50,588
|
*
|
||||||||
David
B. Mueller(3)
|
146,260
|
*
|
||||||||
Jimmie
L. Wade(3)
|
381,574
|
*
|
||||||||
All
executive officers and directors as a group (17 persons)(13)
|
2,910,107
|
2.7%
|
(1) | According to a Schedule 13G filed with the SEC on February 12, 2007 by T. Rowe Price Associates, Inc., “these securities are owned by various individual and institutional investors which T. Rowe Price Associates, Inc. (Price Associates) serves as investment adviser with power to direct investments and/or sole power to vote the securities. For purposes of the reporting requirements of the Securities Exchange Act of 1934, Price Associates is deemed to be a beneficial owner of such securities; however, Price Associates expressly disclaims that it is, in fact, the beneficial owner of such securities.” |
(2) | Includes 829 shares of our common stock with respect to deferred stock units and 677,500 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(3) | Includes shares of our common stock subject to options beneficially owned by the following persons and exercisable within 60 days of March 28, 2007: Mr. Coppola, 628,000 options; Mr. Klasing, 450,000 options; Mr. Moore, 45,000 options; Mr. Mueller, 140,000 options; and Mr. Wade, 345,000 options. Also includes shares of our restricted stock owned by the following persons: Mr. Coppola, 13,148 shares; Mr. Klasing, 5,259 shares, Mr. Moore, 5,588 shares, Mr. Mueller, 5,916 shares and Mr. Wade, 6,574 shares. Mr. Mueller also owns 21 shares of our common stock with respect to deferred stock units. |
(4) | Includes 2,808 shares of our common stock issuable with respect to deferred stock units and 15,000 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(5) | Includes 2,352 shares of our common stock issuable with respect to deferred stock units and 11,667 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(6) | Includes 1,430 shares of our common stock issuable with respect to deferred stock units and 2,500 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(7) | Includes 3,296 shares of our common stock issuable with respect to deferred stock units and 10,417 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(8) | Includes 2,699 shares of our common stock issuable with respect to deferred stock units and 21,250 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(9) | Includes 2,490 shares of our common stock issuable with respect to deferred stock units and 37,500 shares of our common stock subject to options exercisable within 60 days of March 28, 2007. |
(10) | Includes 2,838 shares of our common stock issuable with respect to deferred stock units and 40,624 shares subject to options beneficially owned and exercisable within 60 days of March 28, 2007. |
(11) | Includes 2,906 shares of our common stock issuable with respect to deferred stock units and 41,250 shares subject to options and exercisable within 60 days of March 28, 2007. |
(12) | Includes indirect ownership of 54,000 shares held by Mr. Klasing’s wife. |
(13) | Includes 25,851 shares of our common stock issuable with respect to deferred stock units, 48,055 shares of our common stock with respect to restricted common stock and 2,616,708 shares of our common stock subject to options beneficially owned and exercisable within 60 days of March 28, 2007 by our executive officers and directors. |
Directors | Stock valued at 3 times their annual retainer |
Chairman, President and CEO | Stock valued at 3 times their annual base salary |
Other Executive Committee Members | Stock valued at 1 times their annual base salary |
2006
|
2005
|
||
($
in thousands)
|
($
in thousands)
|
||
Audit
Fees (a)
|
$1,477
|
$1,247
|
|
Audit-Related
Fees (b)
|
-
|
81
|
|
Tax
Fees (c)
|
-
|
32
|
|
All
Other Fees
|
-
|
-
|
|
Total
|
$1,477
|
$1,360
|
(a) | Fees for audit services billed in 2006 and 2005 consisted of: | |
· | audit of our annual financial statements | |
· | reviews of our quarterly financial statements | |
· | attestation of management’s assessment and effectiveness of internal controls as required by the Sarbanes-Oxley Act of 2002, Section 404 | |
· | statutory and regulatory audits, consents and other services related to SEC matters | |
(b) | 2005 audit-related fees consist of due diligence services associated with mergers and acquisitions. | |
(c) | Fees for tax services related to property taxes and an annual license fee for tax preparation software. Professional service firms other than Deloitte provide other tax consulting and preparation services. These fees are not included in the table above. |
· |
appointed
Deloitte & Touche LLP as the independent registered public accounting
firm for fiscal year 2006;
|
· |
met
with management and the independent accountants to review and discuss
Advance’s critical accounting policies and significant
estimates;
|
· |
met
with management and the independent accountants to review and approve
the
fiscal year 2006 audit plan;
|
· |
met
regularly with both the independent accountants and internal audit
outside
the presence of management;
|
· |
met
with management and the independent accountants to review the audited
financial statements for the year ended December 30, 2006, and internal
controls over financial reporting as of December 30,
2006;
|
· |
reviewed
and approved the quarterly and annual reports prior to filing with
the
SEC;
|
· |
reviewed
and approved the quarterly earnings press releases and other financial
press releases;
|
· | met with the Chief Internal Audit Executive to review, among other things, the audit plan, test work, findings and recommendations, and staffing; |
· |
reviewed
the processes by which risk is assessed and mitigated;
and
|
· |
completed
all other responsibilities under the audit committee
charter.
|
Stock
Options
|
Deferred
Stock Units
|
|
All named executive officers as a group (1) |
585,000
|
-
|
All Non-employee Directors as a group (2) |
67,500
|
7,425
|
All employees, excluding named executive officers, as a group |
1,463,500
|
-
|
Number
of shares to be issued
upon
exercise of outstanding
options,
warrants, and rights
#
|
Weighted-average
exercise
price of
outstanding
options,
warrants,
and rights
$
|
Number
of securities
remaining
awailable
for
future issuance
under
equity
compensation
plans
#
|
||||||||
Equity
compensation plans approved by stockholders
|
7,269
|
|
$
29.31
|
4,565
|
||||||
Equity
compensation plans not approved by stockholders
|
-
|
-
|
-
|
|||||||
Total
|
7,269
|
|
$
29.31
|
4,565
|
· | Company revenues |
· |
Company
operating earnings or margin
|
· |
Earnings
before or after taxes, interest, depreciation, and/or
amortization
|
· |
Inventory
productivity measures such as inventory turns
|
· |
Share
price (including, but not limited to, growth measures and total
shareholder return)
|
· |
Earnings
per share
|
· |
Economic
profit or value created
|
· |
Return
measures (including, but not limited to, return on assets, capital,
invested capital, equity sales or revenue)
|
· |
Strategic
business criteria (including, but not limited to, meeting specified
goals
relating to market penetration, geographic business expansion, cost
targets, customer or employee satisfaction, or acquisitions or
divestitures of subsidiaries, affiliates or joint
ventures)
|